PharmaIN’s business strategy consists of two core goals:
PharmaIN is seeking collaborative relationships to capitalize on synergies between our drug delivery platforms and therapeutic molecules with formulation needs. Of particular interest are those molecules which are currently limited by very short in vivo half-lives, and approved molecules which would have enhanced safety, efficacy, or convenience in our delivery system.
Interested parties are encouraged to inquire about the availability of any of our products or platform technologies for out-licensing.
For Licensing and Business Development information, please contact us:
| Jeffrey D. Wellhausen, PhD | |
| Manager, Business Development | |
| Email: | corpdev@pharmain.com |
| Phone: | (206) 568-1493 |
| Fax: | (206) 860-6762 |